National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

filgrastim
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:granulocyte colony-stimulating factor
Recombinant Methionyl Human Granulocyte Colony Stimulating Factor
US brand name:Neupogen
Abbreviations:G-CSF
r-metHuG-CSF



Previous:ferumoxytol, FGFR1 receptor antagonist FP-1039, fibrin sealant, Fidelin, figitumumab
Next:finasteride, Flagyl, flavone acetic acid, flavonoid tablet, flaxseed

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov